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ABSTRACT 
The biological market is increasing day by day, so the regulatory bodies are becoming more stringent to maintain the quality of the product. To meet 
the highest quality standards, it is necessary to assess the quality of the product, in each and every step of the bio-therapeutic drug manufacturing. 
Originator molecule manufactures usually define their own standards, but where as a biosimilar producer should do head to head comparison with 
the standard molecule, in order to prove it as closely similar to the standard with respect to structure and function. 
In this paper, we compared urate oxidase produced in E. coli with the marketing Elitek which is expressed in yeast. We used various methods to 
determine its molecular weight, structural integrity, In-vitro bioassay and other methods to compare with the standard. Integrity by DSS cross 
linking is first of its kind for urate oxidase, expressed in E.coli. 
Keywords: Analytical methods, Uricase, SDS-PAGE, RP-HPLC, and DSS cross linking. 
 
INTRODUCTION 
The present biotechnology industry usually employs bacteria, yeast, 
insect cells or mammalian cells for the production of high value 
therapeutic proteins. These products are complex in structure, size 
and biological activity. The path of a biotechnology product 
manufacture is cloning, cell banking, fermentation, purification and 
formulation. The quality and safety of the end product depends on 
the in-process. A minor change in the process leads to major changes 
in the quality of the product characteristics. So the quality 
assessment of the product has to be carried throughout the process 
starting from cloning to product release.  
Thus, Analytical methods play a crucial role in the process 
development and production of a product. Therapeutic proteins are 
life saving products, thus the purity, identity, stability and 
performance of the product is of great importance.  
Regulatory bodies have defined the limit of impurities, identity and 
quality of the product. It is necessary to meet the defined 
specification by the regulatory bodies to move the product into the 
market. So, Quality control plays a major role to market a 
manufactured product. Uricase (Urate oxidase) is human 
therapeutic protein used to treat Hyperuricemia [1] and tumor lysis 
syndrome[2], which are associated with the chemotherapeutic 
treament of cancer.In this research paper, we used various analytical 
tests to analyse the structural, physico-chemical and biological 
properties of urate oxidase showing its comparability with the 
originator molecule.  
MATERIALS AND METHODS 
Chromatography sorbents and columns were purchased from GE life 
sciences, chemicals were purchased from Sigma Aldrich, Iso-Electric 
Focusing pI marker were purchased from Biorad, glassware and 
other chemicals were of analytical grade purchased from local 
companies. Urate oxidase from Aspergilus flavus was cloned in E.coli 
[3] and then, the protein was purified using various 
chromatographic methods (submitted for publication).The purified 
protein was used for the study. 
Molecular mass determination by SDS-PAGE 
The molecular weight of uricase was determined by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) as per the 
method described by Laemmli [4]. The analysis was carried out 
using 12% resolution gel. The protein bands were detected by silver 
staining method [5].  
Determination of pI by Iso-electric focusing (IEF) 
The pI of the protein is determined by co-running the protein of 
interest and the ready to use pI markers in an electrophoresis. By 
exploiting the position of the known pI protein band, the pI of the 
Uricase can be determined [6].The protocol engaged is according to 
the Biorad’s IEF instruction manual [7]. 
Identity of urate oxidase by western blotting 
Purified uricase was loaded in the gel and allowed to run until the 
blue dye entered into the gel front and the bands were transferred to 
the PVDF membrane by semi-dry blot apparatus (Bio-Rad) for 40 
min at 10 volts. The transferred membrane was blocked with 3% 
BSA in 1X PBS and incubated for overnight at 40
Determination of purity by reverse phase- high performance 
liquid chromatography (RP-HPLC) 
C with primary 
antibodies raised against the Rasburicase in mouse (Data not 
shown). Then the membrane was washed thrice with 1X PBS 
supplemented with 0.1 % Tween, later the membrane was incubated 
for 2 hours in 1X PBS supplemented with secondary antibody 
conjugated with Alkaline phosphatase. Then the membrane was 
washed thrice with 1X PBS supplemented with 0.1 % Tween. Finally, 
the membrane was developed by NBT/ BCIP [8,9]. 
10 µg of purified sample was loaded onto to the Chromosil C18 
column (250 mm X 4.6 mm, 5 µm) which was pre equilibrated with 
0.08% trifluoro acetic acid (TFA) in WFI and eluted by using 0.08% 
TFA in solvent with acetonitrile/water (6:4 v/v ratio) with a run 
time of 35 minutes [10]. The purity of the peak was analysed. 
Determination of homo-tetramer confirmation by chemical 
cross linking of uricase with Disuccinimidyl suberate (DSS) 
In order to determine the integrity of the uricase as homo-tetramer, 
uricase was cross linked with the DSS, which usually reacts and links 
the molecule which is near to the 100A vicinity [11,12,13,14].0.1and 
0.2 nmol of purified uricase was cross-linked by incubating with 
0.15 mM DSS for 30 min at 250
Determination of In-vitro activity of Uricase 
C. The reaction was stopped by 
adding glycine to a final concentration of 50 mM. The cross-linked 
proteins were analysed by on 12% SDS-PAGE gel under reducing 
conditions, and the gels were developed by silver staining [5].  
In-vitro activity assay was carried out in 0.1 M sodium borate buffer 
(pH8.6) at 25°C, according to the method described by Mahler. [15]. 
The decrease in the uric acid concentration in the sample during the 
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enzymatic reaction was measured at 293nm.One unit (U) of enzyme 
activity is defined as the amount of enzyme that catalyzes the 
oxidation of 1 µmol of uric acid per min at 37°C. 
RESULTS AND DISCUSSION 
The basic properties of Uricase were shown in the Table 1. 
 
Table 1: It shows the basic properties of Uricase 
Basic features of Uricase 1. pH stability of uricase – 8.0 
2. Optimum temperature - 25-370
3. pI of the protein - 7.5- 8.0 
C 
4. Molecular weight of monomer - 34.0 kDa 
5. Molecular weight of Tetramer - 136 kDa 
 
Molecular mass determination by SDS-PAGE 
SDS-PAGE is tool to identify the molecular mass of the protein, the 
identity of the protein and visualize the impurities in the gel, if any 
present. Determination of the molecular weight of uricase is an 
important method to identify the protein and to confirm the primary 
structure. Molecular weight of purified urate oxidase was 
determined as around 34.0 kDa by SDS-PAGE analysis (Figure 1). 
 
 
Fig. 1: It shows the determination of molecular weight of 
Uricase by SDS-PAGE 
 
Determination of pI by Iso-Electric Focusing (IEF) 
The change in the pI of the protein leads to the instability of the 
product and also loss of activity of the protein. Hence, it is essential 
to determine the pI of the protein during the process development, 
manufacturing, and the drug product. The pI of the protein is 
determined by IEF. The pI of the purified urate oxidase is around 
7.5-8.0 (Figure 2). 
 
 
Fig. 2: It shows the pI of purified recombinant urate oxidase 
using IEF 
Identity of urate oxidase by Western Blotting 
Identity of the sample was confirmed by western blotting. Western 
blot analysis showed that the induction band confirmed the uricase 
(Figure 3). 
 
Fig. 3: It shows the western blot of purified recombinant urate 
oxidase 
 
Determination of purity by RP-HPLC 
Purity of the sample was determined by RP-HPLC with C18 column, 
revealed that uricase was eluted at 27.8 min and more than 99.0 % 
pure (Figure 4). 
 
Fig. 4: It shows the RP-HPLC of purified recombinant urate 
oxidase 
 
Determination of homo-tetramer confirmation by chemical 
cross linking of uricase with Disuccinimidyl suberate (DSS) 
Urate oxidase has four monomers. The protein is unstable in the 
monomeric form and the stability is increased in the tetrameric form 
through the oligomeric association [16]. During the oligomeric 
association of the tetramers, they exhibit three different types of 
interface between the monomers. The active site of these monomers 
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is located at the interface [17].Integrity of the sample was 
determined by cross linking with the DSS. DSS cross linking of 
uricase confirmed the homo-tetrameric confirmation of the 
molecule (Figure 5).  
 
Fig. 5: It shows the DSS cross linking of purified recombinant 
urate oxidase for the determination of homo-tetramer 
 
Determination of In-vitro activity of Uricase 
In-vitro activity determination of Uricase was carried out and the 
results showed the substrate enzymatic utilization (Figure 6).The 
specific activity of the purified urate oxidase is 18.2 enzyme units 
per mg of protein, which is similar to the standard. As the purified 
protein shows similar activity to the standard, the integrity of the 
protein is also addressed [16]. 
 




Various analytical methods to characterise the purified protein are 
addressed in this paper. The molecular weight of the purified urate 
oxidase was around 34.0 kDa by SDS-PAGE analysis. Identity of the 
protein was confirmed by western blotting. Isoform distribution of 
the protein was acknowledged by IEF. Potency and purity of the 
product was analyzed by In-vitro assay and RP- HPLC respectively. 
The activity of the protein was determined by the enzymatic 
degradation of uric acid. Homo-tetrameric integrity of the sample 
was determined by using DSS cross linking, which is first of its kind 
for urate oxidase, expressed in E.coli. 
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